Diabetes Bites Newsletter: January 2017

Home/Diabetes Bites Newsletter: January 2017
Diabetes Bites Newsletter: January 2017 2017-01-19T18:56:27+00:00
diabetes bites newsletter

January 2017

2301, 2017

January 2017 Survey – How do you think the Trump administration will impact health care for people with diabetes?

By | January 23rd, 2017|

View the results of last month's survey and VOTE a new January survey!

1801, 2017

Tresiba gains FDA approval for use in children and adolescents

By | January 18th, 2017|

Children and adolescents age 1 and up now have another option in basal insulin. On December 19, 2016, Novo Nordisk announced that the FDA approved an expanded indication for Tresiba (insulin degludec injection 100 U/mL, 200 U/mL).

1801, 2017

New Lilly program provides discounted insulin pricing

By | January 18th, 2017|

If you are paying full retail pricing at the pharmacy for insulin because you do not have insurance, or are in the deductible phase of your high-deductible insurance plan, you may soon be able to get a little relief.

1801, 2017

New Hope: Glucagon for the dual hormone artificial pancreas

By | January 18th, 2017|

We are all so eager for a commercially available closed-loop "bionic pancreas" system to hit the market. But glucagon isn't stable for any great length of time after it is reconstituted, so researchers are working on developing a more stable version of it. Read on to learn more about progress on that front!